Fevara plc buys São Paulo production facility to deepen Brazil push
Fevara plc (LSE: FVA) has completed the acquisition of a high-specification production facility in northern São Paulo State, Brazil. This is the company’s second strategic move in the country following the December 2025 acquisition of Macal, a distributor serving Mato Grosso do Sul.
The deal gives Fevara local manufacturing for its specialist, high margin livestock supplements and strengthens its distribution footprint in the world’s largest beef producing country. Management expects production and distribution from the new site to begin in Q2 next year.
What Fevara is building in Brazil and why it matters
Fevara plans to localise production of its differentiating supplementation products already sold in the UK, Europe and the US, tailored for Brazilian herds. Local production should help the Group put product closer to customers and scale more efficiently across key ranching regions.
Distribution will run through Macal in Mato Grosso do Sul and the newly acquired São Paulo operation, with further expansion initially planned into Goiás and Minas Gerais. That network would give Fevara access to a combined cattle population of approximately 100 million head of beef cattle, within a country that has more than 200 million cattle overall.
The company also plans to add low-moisture block production capability at the site, a feed supplement format widely used in extensive grazing systems. As Chief Executive Joshua Hoopes put it, the site is a “compelling opportunity to unlock the potential of existing assets” and accelerate the rollout of Fevara’s specialist nutrition products across the region.
Deal terms and funding in plain English
The acquisition comprises the freehold property and an existing operating business. Initial consideration totalled £4.3 million, of which £4.0 million relates to the freehold and the balance to the operating business.
There is a deferred consideration due in March 2027 that depends on the performance of the acquired mineral distribution business during 2026. In other words, it functions like an earn-out, and the company states it will be self-funding. The transaction was funded from the Group’s existing resources.
| Item | Detail |
|---|---|
| Initial consideration | £4.3 million |
| Freehold property component | £4.0 million |
| Operating business component | £0.3 million |
| Deferred consideration | Dependent on 2026 performance, due March 2027, self-funding (amount not disclosed) |
| Funding source | Existing resources |
| Location | Northern São Paulo State, Brazil |
| Production start | Expected Q2 next year |
| Initial distribution footprint | São Paulo State and Mato Grosso do Sul, with Goiás and Minas Gerais to follow |
| Target market access | Approximately 100 million head of beef cattle across targeted states |
| Brazil cattle population | More than 200 million |
Strategic logic: a bigger stage for high margin products
Fevara’s core proposition is research-proven livestock supplements designed for extensive grazing systems. Shifting production onshore in Brazil should support the rollout of its higher margin lines and tailor formulations to local conditions, which can improve customer uptake. It also strengthens the Group’s control over quality, lead times and distribution in a market with scale that few others can match.
Importantly, this move aligns with Fevara’s stated vision to be the global expert in extensive livestock supplements and its strategy of targeted investment in high-potential markets. Brazil sits at the top of that list, having recently overtaken the United States as the world’s largest beef producing country, according to USDA data published in January 2026.
Execution timeline and what to watch in 2026
The company expects production and distribution from the São Paulo facility to commence in Q2 next year. That gives several milestones to track: installation of low-moisture block capability, regulatory and operating readiness, and early sales momentum through the São Paulo and Macal channels.
The deferred consideration is explicitly tied to 2026 performance of the acquired mineral distribution business, which creates clear incentives for delivery. Investors should look for operational updates on product mix, state-by-state rollout into Goiás and Minas Gerais, and evidence that local manufacturing is expanding the addressable customer base.
Positives for investors
- Strategic fit: Adds local manufacturing in a priority market with scale and growth potential.
- Distribution synergy: Builds on the Macal acquisition to create a multi-state network.
- Focused products: Emphasis on specialist, high margin supplements that underpin profitability.
- Prudent structure: Majority of initial outlay tied to freehold property, with performance-based deferred consideration that is self-funding.
- Clear near-term catalyst: Production targeted in Q2 next year provides a tangible timeline.
Watch-outs and what’s not disclosed
- Financial uplift not disclosed: No revenue, EBITDA or profit figures provided for the acquired business.
- Deferred consideration amount not disclosed: We know timing and that it is performance-linked, but not the potential size.
- Capex and integration costs not disclosed: Adding low-moisture block capability may require investment and ramp-up time.
- Execution risk: Delivering customised products and building out distribution across multiple states requires strong operational discipline.
About Fevara at a glance
Fevara develops, manufactures and markets livestock supplements under recognised brands including Crystalyx, Horslic, Horslyx, Scotmin Nutrition, SmartLic, Tracesure Advanced and Macal. The Group is headquartered in Carlisle, Cumbria, with five manufacturing sites across the UK, US and Brazil and three operational joint ventures in Germany and the US. It serves customers in more than 20 countries and has been listed on the London Stock Exchange since 1972.
My take: a sensibly structured step-up in Brazil
This looks like a sensible and capital-light way to scale in a must-win market for Fevara. Buying a freehold-backed site, layering on specialist production, and plugging into an expanding, state-based distribution network is a coherent plan that plays to the Group’s strengths.
The lack of disclosed financials means we cannot size the near-term earnings impact, but the high margin product focus and performance-linked earn-out are both encouraging signals. Delivering Q2 next year production and visible traction in São Paulo, Mato Grosso do Sul, and the next two states will be the proof points to watch.
Net-net, a positive strategic move with clear execution milestones. If management hits the rollout timetable and proves the model across those initial states, Brazil could become a powerful growth engine for Fevara.
